Fig. 1From: ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomesHigh grade disease-free survival Kaplan-Meiers curves based on stratification according stage/gradeBack to article page